Loading market data...
Latest Top News
Emcure’s Bold Move: Fully Acquires Zuventus to Power Next Pharma Leap
Emcure Pharmaceuticals has successfully acquired 4,095,180 equity shares of Zuventus Healthcare, representing 20.42% of its total issued and paid-up capital for an aggregate consideration of Rs. 7,249 million. This acquisition makes Zuventus a wholly owned subsidiary of Emcure, marking a key mile...
Stay Ahead – Explore Now! IndiGo Flyer Faces Heavy Financial Loss After Flight Cancellation






